Insights into the chemistry and biology of the I-Ag7 class II molecule.
暂无分享,去创建一个
[1] G. Nepom,et al. Modulation of HLA-DQ binding properties by differences in class II dimer stability and pH-dependent peptide interactions. , 1996, Journal of immunology.
[2] E. Unanue,et al. Appreciating the Complexity of MHC Class II Peptide Binding: Lysozyme Peptide and I‐Ak , 1996, Immunological reviews.
[3] D. Fremont,et al. Structures of an MHC Class II Molecule with Covalently Bound Single Peptides , 1996, Science.
[4] C. Fathman,et al. Breaking self-tolerance in nonobese diabetic mice , 1996, The Journal of experimental medicine.
[5] E. Unanue,et al. The class II MHC I-Ag7 molecules from non-obese diabetic mice are poor peptide binders. , 1996, Journal of immunology.
[6] Partho Ghosh,et al. The structure of an intermediate in class II MHC maturation: CLIP bound to HLA-DR3 , 1995, Nature.
[7] L. Chuang. Immunogenetics and IDDM , 1994 .
[8] S. Tonegawa,et al. A differential-avidity model for T-cell selection. , 1994, Immunology today.
[9] Don C. Wiley,et al. Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide , 1994, Nature.
[10] C. Janeway,et al. Self peptides isolated from MHC glycoproteins of non-obese diabetic mice. , 1994, Journal of immunology.
[11] E. Thorsby,et al. Binding of peptides to HLA-DQ molecules: peptide binding properties of the disease-associated HLA-DQ(α1*0501, β1*0201) molecule , 1994 .
[12] D. Wraith,et al. An autoantigenic T cell epitope forms unstable complexes with class II MHC: a novel route for escape from tolerance induction. , 1993, International immunology.
[13] E. Unanue,et al. Presentation of beta-cell antigens to CD4+ and CD8+ T cells of non-obese diabetic mice. , 1993, Journal of immunology.
[14] L. Adorini,et al. Prevention of autoimmune diabetes in non-obese diabetic mice by treatment with a class II major histocompatibility complex-blocking peptide , 1993, The Journal of experimental medicine.
[15] E. Unanue,et al. Identification of two distinct properties of class II major histocompatibility complex-associated peptides. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[16] William S. Lane,et al. Predominant naturally processed peptides bound to HLA-DR1 are derived from MHC-related molecules and are heterogeneous in size , 1992, Nature.
[17] E. Unanue,et al. Identification of the naturally processed form of hen egg white lysozyme bound to the murine major histocompatibility complex class II molecule I-Ak. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[18] A Sette,et al. Peptides presented to the immune system by the murine class II major histocompatibility complex molecule I-Ad. , 1992, Science.
[19] A. Rudensky,et al. Sequence analysis of peptides bound to MHC class II molecules , 1991, Nature.
[20] R. Germain,et al. A role for peptide in determining MHC class II structure , 1991, Nature.
[21] I. Cohen,et al. Vaccination against autoimmune mouse diabetes with a T-cell epitope of the human 65-kDa heat shock protein. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[22] R. Houghten,et al. Distinction between immunogenicity and tolerogenicity among HBcAg T cell determinants. Influence of peptide-MHC interaction. , 1989, Journal of immunology.
[23] J. Todd,et al. HLA-DQβ gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus , 1987, Nature.
[24] H. Mcdevitt,et al. The first external domain of the nonobese diabetic mouse class II I-A beta chain is unique. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[25] M. Dorf,et al. The NOD mouse: recessive diabetogenic gene in the major histocompatibility complex. , 1986, Science.
[26] P. Morris,et al. A Method for Isolation of Islets of Langerhans from the Human Pancreas , 1984, Diabetes.
[27] E. Unanue,et al. Identification of a macrophage antigen-processing event required for I-region-restricted antigen presentation to T lymphocytes. , 1981, Journal of immunology.
[28] E. Unanue,et al. Identification of the T-cell and Ia contact residues of a T-cell antigenic epitope , 1987, Nature.
[29] E. Unanue,et al. Binding of immunogenic peptides to Ia histocompatibility molecules , 1985, Nature.
[30] E. Unanue,et al. Decrease in macrophage antigen catabolism caused by ammonia and chloroquine is associated with inhibition of antigen presentation to T cells. , 1982, Proceedings of the National Academy of Sciences of the United States of America.